Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 45 results.
User Information
Export Records
  1. 1.   Comprehensive mapping of cell fates in microsatellite unstable cancer cells supports dual targeting of WRN and ATR
  2. Zong, Dali; Koussa, Natasha C; Cornwell, James A; Pankajam, Ajith V; Kruhlak, Michael J; Wong, Nancy; Chari,Raj; Cappell, Steven D; Nussenzweig, André
  3. Genes & Development. 2023, Nov 06; 37(19-20): 913-928.
  1. 2.   Genomic and evolutionary classification of lung cancer in never smokers
  2. Zhang, Tongwu; Joubert, Philippe; Ansari-Pour, Naser; Zhao, Wei; Hoang, Phuc H.; Lokanga, Rachel; Moye, Aaron L.; Rosenbaum, Jennifer; Gonzalez-Perez, Abel; Martinez-Jimenez, Francisco; Castro, Andrea; Muscarella, Lucia Anna; Hofman, Paul; Consonni, Dario; Pesatori, Angela C.; Kebede, Michael; Li, Mengying; Rothberg, Bonnie E. Gould; Peneva, Iliana; Schabath, Matthew B.; Poeta, Maria Luana; Costantini, Manuela; Hirsch, Daniela; Heselmeyer-Haddad, Kerstin; Hutchinson,Amy; Olanich, Mary; Lawrence,Scott; Lenz,Petra; Duggan, Maire; Bhawsar, Praphulla M. S.; Sang, Jian; Kim, Jung; Mendoza, Laura; Saini, Natalie; Klimczak, Leszek J.; Islam, S. M. Ashiqul; Otlu, Burcak; Khandekar, Azhar; Cole,Nathan; Stewart, Douglas R.; Choi, Jiyeon; Brown, Kevin M.; Caporaso, Neil E.; Wilson, Samuel H.; Pommier, Yves; Lan, Qing; Rothman, Nathaniel; Almeida, Jonas S.; Carter, Hannah; Ried, Thomas; Kim, Carla F.; Lopez-Bigas, Nuria; Garcia-Closas, Montserrat; Shi, Jianxin; Bosse, Yohan; Zhu, Bin; Gordenin, Dmitry A.; Alexandrov, Ludmil B.; Chanock, Stephen J.; Wedge, David C.; Landi, Maria Teresa
  3. Nature genetics. 2021, Sep; 53(9): 1348-1359.
  1. 3.   Sensitivity of Oncogenic KRAS-Expressing Cells to CDK9 Inhibition
  2. Lai, Lick Pui; Brel, Viviane; Sharma, Kanika; Frappier, Julia; Le-Henanf, Nadia; Vivet, Bertrand; Muzet, Nicolas; Schell, Emilie; Morales, Renaud; Rooney, Eamonn; Basse, Nicolas; Yi,Ming; Lacroix, Frederic; Holderfield, Matthew; Englaro, Walter; Marcireau, Christophe; Debussche, Laurent; Nissley,Dwight; McCormick, Frank
  3. SLAS DISCOVERY. 2021, Apr 24; 26(7, SI): 922-932.
  1. 4.   Molecular Features of Cancers Exhibiting Exceptional Responses to Treatment
  2. Wheeler, David A; Takebe, Naoko; Hinoue, Toshinori; Hoadley, Katherine A; Cardenas, Maria F; Hamilton, Alina M; Laird, Peter W; Wang, Linghua; Johnson, Adrienne; Dewal, Ninad; Miller, Vincent; Piñeyro, David; Castro de Moura, Manuel; Esteller, Manel; Shen, Hui; Zenklusen, Jean Claude; Tarnuzzer, Roy; McShane, Lisa M; Tricoli, James V; Williams, Paul M; Lubensky, Irina; O'Sullivan-Coyne, Geraldine; Kohn, Elise C; Little, Richard F; White, Jeffrey; Malik, Shakun; Harris, Lyndsay; Weil, Carol; Chen, Alice P; Karlovich,Chris; Rodgers, Brian; Shankar, Lalitha; Jacobs, Paula; Nolan, Tracy; Hu, Jianhong; Muzny, Donna M; Doddapaneni, Harshavardhan; Korchina, Viktoriya; Gastier-Foster, Julie; Bowen, Jay; Leraas, Kristen; Edmondson,Elijah; Doroshow, James H; Conley, Barbara A; Ivy, S Percy; Staudt, Louis M
  3. Cancer Cell. 2021, Jan 11; 39(1): 38-53.e7.
  1. 5.   Structural basis for DNA damage-induced phosphoregulation of MDM2 RING domain
  2. Magnussen, Helge M.; Ahmed, Syed F.; Sibbet, Gary J.; Hristova, Ventzislava A.; Nomura, Koji; Hock, Andreas K.; Archibald, Lewis J.; Jamieson, Andrew G.; Fushman, David; Vousden, Karen H.; Weissman, Allan M.; Huang, Danny T.
  3. Nature communications. 2020, Apr 29; 11(1):
  1. 6.   RAD52 S346X Variant Reduces Breast Cancer Risk in BRCA2 Mutation Carriers
  2. Biswas,Kajal; Sharan,Shyam
  3. Molecular oncology. 2020, Apr 07;
  1. 7.   SL-BioDP: Multi-Cancer Interactive Tool for Prediction of Synthetic Lethality and Response to Cancer Treatment
  2. Deng,Xiang; Das, Shaoli; Valdez,Kristin; Camphausen, Kevin; Shankavaram, Uma
  3. Cancers. 2019, Nov; 11(11): pii: E1682.
  1. 8.   BRCA1 Haploinsufficiency Is Masked by RNF168-Mediated Chromatin Ubiquitylation
  2. Zong, Dali; Adam, Salome; Wang, Yifan; Sasanuma, Hiroyuki; Callen, Elsa; Murga, Matilde; Day, Amanda; Kruhlak, Michael J.; Wong, Nancy; Munro, Meagan; Chaudhuri, Arnab Ray; Karim,Baktiar; Xia, Bing; Takeda, Shunichi; Johnson, Neil; Durocher, Daniel; Nussenzweig, Andre
  3. Molecular cell. 2019, MAR 21; 73(6): 1267-+.
  1. 9.   Cyclin-dependent kinase 1 (Cdk1) is essential for cell division and suppression of DNA re-replication but not for liver regeneration
  2. Diril, M. K.; Ratnacaram, C. K.; Padmakumar, V. C.; Du, T. H.; Wasser, M.; Coppola, V.; Tessarollo, L.; Kaldis, P.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2012, Mar; 109(10): 3826-3831.
  1. 10.   Advances in using PARP inhibitors to treat cancer
  2. Kummar, S.; Chen, A.; Parchment, R. E.; Kinders, R. J.; Ji, J.; Tomaszewski, J. E.; Doroshow, J. H.
  3. Bmc Medicine. 2012, Mar; 10
  1. 11.   The p53 Inhibitor MDM2 Facilitates Sonic Hedgehog-Mediated Tumorigenesis and Influences Cerebellar Foliation
  2. Malek, R.; Matta, J.; Taylor, N.; Perry, M. E.; Mendrysa, S. M.
  3. Plos One. 2011, Mar; 6(3): 13.
  1. 12.   Rb/Cdk2/Cdk4 triple mutant mice elicit an alternative mechanism for regulation of the G(1)/S transition
  2. Li, W.; Kotoshiba, S.; Berthet, C.; Hilton, M. B.; Kaldis, P.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2009 106(2): 486-491.
  1. 13.   Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms
  2. Satyanarayana, A.; Kaldis, P.
  3. Oncogene. 2009 28(33): 2925-2939.
  1. 14.   Discovery of new pyridoacridine alkaloids from Lissoclinum cf. badium that inhibit the ubiquitin ligase activity of Hdm2 and stabilize p53
  2. Clement, J. A.; Kitagaki, J.; Yang, Y.; Saucedo, C. J.; O'Keefe, B. R.; Weissman, A. M.; Mckee, T. C.; McMahon, J. B.
  3. Bioorganic & Medicinal Chemistry. 2008 16(23): 10022-10028.
  1. 15.   Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition
  2. Dang, D. T.; Chun, S. Y.; Burkitt, K.; Abe, M.; Chen, S.; Havre, P.; Mabjeesh, N. J.; Heath, E. I.; Vogelzang, N. J.; Cruz-Correa, M.; Blayney, D. W.; Ensminger, W. D.; Croix, B. S.; Dang, N. H.; Dang, L. H.
  3. Cancer Research. 2008 68(6): 1872-1880.
  1. 16.   Targeting tumor cells expressing p53 with a water-soluble inhibitor of Hdm2
  2. Kitagaki, J.; Agama, K. K.; Pommier, Y.; Yang, Y. L.; Weissman, A. M.
  3. Molecular Cancer Therapeutics. 2008 7(8): 2445-2454.
  1. 17.   Dll4 activation of Notch signaling reduces tumor vascularity and inhibits tumor growth
  2. Segarra, M.; Williams, C. K.; Sierra, M. D.; Bernardo, M.; McCormick, P. J.; Maric, D.; Regino, C.; Choyke, P.; Tosato, G.
  3. Blood. 2008 112(5): 1904-1911.
  1. 18.   Inactivation of the mouse Magel2 gene results in growth abnormalities similar to Prader-Willi syndrome
  2. Bischof, J. M.; Stewart, C. L.; Wevrick, R.
  3. Human Molecular Genetics. 2007, Nov; 16(22): 2713-2719.
  1. 19.   The imprinted gene Magel2 regulates normal circadian output
  2. Kozlov, S. V.; Bogenpohl, J. W.; Howell, M. P.; Wevrick, R.; Panda, S.; Hogenesch, J. B.; Muglia, L. J.; Van Gelder, R. N.; Herzog, E. D.; Stewart, C. L.
  3. Nature Genetics. 2007, Oct; 39(10): 1266-1272.
  1. 20.   Vascular defects and liver damage by the acute inactivation of the VHL gene during mouse embryogenesis
  2. Hong, S. B.; Furihata, M.; Baba, M.; Zbar, B.; Schmidt, L. S.
  3. Laboratory Investigation. 2006, Jul; 86(7): 664-675.
  1. 21.   Combined loss of Cdk2 and Cdk4 results in embryonic lethality and Rb hypophosphorylation
  2. Berthet, C.; Klarmann, K. D.; Hilton, M. B.; Suh, H. C.; Keller, J. R.; Kiyokawa, H.; Kaldis, P.
  3. Developmental Cell. 2006, MAY; 10(5): 563-573.
  1. 22.   Tumor suppression and normal aging in mice with constitutively high p53 activity
  2. Mendrysa, S. M.; O'Leary, K. A.; McElwee, M. K.; Michalowski, J.; Eisenman, R. N.; Powell, D. A.; Perry, M. E.
  3. Genes & Development. 2006, JAN 1; 20(1): 16-21.
  1. 23.   FGFR1 function at the earliest stages of mouse limb development plays an indispensable role in subsequent autopod morphogenesis
  2. Li, C. L.; Xu, X. L.; Nelson, D. K.; Williams, T.; Kuehn, M. R.; Deng, C. X.
  3. Development. 2005, NOV; 132(21): 4755-4764.
  1. 24.   Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models
  2. Difilippantonio, S.; Celeste, A.; Fernandez-Capetillo, O.; Chen, H. T.; San Martin, B. R.; Van Laethem, F.; Yang, Y. P.; Petukhova, G. V.; Eckhaus, M.; Feigenbaum, L.; Manova, K.; Kruhlak, M.; Camerini-Otero, R. D.; Sharan, S.; Nussenzweig, M.; Nussenzweig, A.
  3. Nature Cell Biology. 2005, JUL; 7(7): 675-U56.
  1. 25.   Conditional alleles for activation and inactivation of the mouse Rx homeobox gene
  2. Voronina, V. A.; Kozlov, S.; Mathers, P. H.; Lewandoski, M.
  3. Genesis. 2005, APR; 41(4): 160-164.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel